UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

Frontiers in immunology, 2023-09, Vol.14, p.1241600-1241600

2023

Volltextzugriff (PDF)

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis

Frontiers in immunology, 2023-11, Vol.14, p.1161832-1161832

2023

Volltextzugriff (PDF)

Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors

Bone marrow transplantation (Basingstoke), 2020-02, Vol.55 (2), p.400-408

2020

Volltextzugriff (PDF)

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

Journal of hematology and oncology, 2023-04, Vol.16 (1), p.43-43, Article 43

2023

Volltextzugriff (PDF)

Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis

Clinical lymphoma, myeloma and leukemia, 2024-03, Vol.24 (3), p.158-164

2024

Volltextzugriff (PDF)

Riesgo comparativo de reacción anafiláctica asociada a hierro endovenoso

Evidencia : actualización en la práctica ambulatoria, 2018-01, Vol.20 (4)

Bendek, Georgina Emilia

2018

Volltextzugriff (PDF)

AML-317: Role of KIR Genotype in Acute Myeloid Leukemia Treated with Stem Cell Transplant

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S304-S304

2021

Volltextzugriff (PDF)

Poster: AML-317: Role of KIR Genotype in Acute Myeloid Leukemia Treated with Stem Cell Transplant

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S216-S216

2021

Volltextzugriff (PDF)

Poster: CT-347 Acute Graft-Versus-Host Disease: Risk Scoring and Response to Treatment, Experience From Two Centers

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S188

2022

Volltextzugriff (PDF)

CT-347 Acute Graft-Versus-Host Disease: Risk Scoring and Response to Treatment, Experience From Two Centers

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S444

2022

Volltextzugriff (PDF)

Real World Efficacy Evaluation of Branded and Copy Imatinib in Chronic Myeloid Leukemia: A Retrospective Multicentric Study from Argentina

Blood, 2020-11, Vol.136 (Supplement 1), p.36-37

2020

Volltextzugriff (PDF)

Utilidad del lavado broncoalveolar para la detección microbiológica, y factores asociados, en receptores de trasplante de precursores hematopoyéticos: estudio de cohorte retrospectivo

Revista chilena de infectología, 2023-10, Vol.40 (5), p.481-490

2023

Volltextzugriff (PDF)

CT-163: Role of KIR Genotype in Haploidentical Stem Cell Transplant

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S215-S215

2020

Volltextzugriff (PDF)

Multiple mononeuritis as a manifestation of graft versus host disease

Hematology, Transfusion and Cell Therapy, 2022-04

2022

Volltextzugriff (PDF)

Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S199-S199

2019

Volltextzugriff (PDF)

Recategorization Essential Thrombocythemia (ET) after Review with 2016 WHO Pathological Criteria

Clinical lymphoma, myeloma and leukemia, 2019-09, Vol.19, p.S356-S357

2019

Volltextzugriff (PDF)

Decreased Incidence of CMV Infection with Letermovir Prophylaxis in Alternative Donor Allogeneic Hematopoietic-Cell Transplantation with Post-Transplant Cyclophosphamide, Real-Life Data from Argentina

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S435-S435

2024

Volltextzugriff (PDF)

Riesgo comparativo de reacción anafiláctica asociada a hierro endovenoso

Evidencia : actualización en la práctica ambulatoria, 2018-01, Vol.20 (4)

Georgina Emilia Bendek

2018

Volltextzugriff (PDF)

Imatinib (IM) Treatment In Chronic Myeloid Leukemia (CML). Clinical Practice Limitations

Blood, 2011-11, Vol.118 (21), p.4454-4454

2011

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(5)
Life Sciences & Biomedicine
(5)
Science & Technology
(5)
Hematology
(3)
Immunology
(3)
Oncology
(3)
Argentina
(2)
Chronic Myeloid Leukemia
(2)
Cmv
(2)
Hematopoietic Stem Cell Transplantation
(2)
Leukemia
(2)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(2)
Relapse
(2)
Remission
(2)
Remission Induction
(2)
Retrospective Studies
(2)
Stem Cell Transplantation
(2)
Stem Cells
(2)
Treatment Free Remission
(2)
Accuracy
(1)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis

Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal

Long-Term Follow-Up in Patients With Chronic Myeloid Leukemia Treated With Ponatinib in a Real-World Cohort: Safety and Efficacy Analysis

Riesgo comparativo de reacción anafiláctica asociada a hierro endovenoso

Economic Impact Analysis of Treatment-Free Remission in Chronic Myeloid Leukemia Patients with Sustained Deep Molecular Response in the AST-2018 Trial

AML-317: Role of KIR Genotype in Acute Myeloid Leukemia Treated with Stem Cell Transplant

Poster: AML-317: Role of KIR Genotype in Acute Myeloid Leukemia Treated with Stem Cell Transplant

Poster: CT-347 Acute Graft-Versus-Host Disease: Risk Scoring and Response to Treatment, Experience From Two Centers

CT-347 Acute Graft-Versus-Host Disease: Risk Scoring and Response to Treatment, Experience From Two Centers

Real World Efficacy Evaluation of Branded and Copy Imatinib in Chronic Myeloid Leukemia: A Retrospective Multicentric Study from Argentina

In Pursuit of Surrogate Markers for Treatment-Free Remission in Patients with Chronic Myeloid Leukemia from Argentina Stop Trial

High Level of Successful TKI Discontinuation in Chronic Myeloid Leukemia (CML) Patients: Preliminary Results of AST-Argentina Stop Trial

Utilidad del lavado broncoalveolar para la detección microbiológica, y factores asociados, en receptores de trasplante de precursores hematopoyéticos: estudio de cohorte retrospectivo

Real World Data on Obstetric (OC) and Maternal Complications (MC) Occurring in a Cohort of Patients with Ph Negative Myeloproliferative Neoplasms (MPN): Argentinian Multicentric Study

CT-163: Role of KIR Genotype in Haploidentical Stem Cell Transplant

Multiple mononeuritis as a manifestation of graft versus host disease

Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia

Recategorization Essential Thrombocythemia (ET) after Review with 2016 WHO Pathological Criteria

Decreased Incidence of CMV Infection with Letermovir Prophylaxis in Alternative Donor Allogeneic Hematopoietic-Cell Transplantation with Post-Transplant Cyclophosphamide, Real-Life Data from Argentina

Riesgo comparativo de reacción anafiláctica asociada a hierro endovenoso

"M3-M6" Molecular Response Evolution As Early Predictor of Outcome Considering Generic Vs Branded TKIs for Chronic Myeloid Leukemia (CML): An Argentine Multicentric Study

Therapeutic Approach to Advanced Follicular Lymphoma at Diagnosis: An Argentinian Survey

Imatinib (IM) Treatment In Chronic Myeloid Leukemia (CML). Clinical Practice Limitations

Suchergebnisse filtern